MPS IV, also known as Morquio syndrome, is a rare genetic disorder caused by the deficiency of specific enzymes needed to break down certain sugars in the body. This leads to the accumulation of glycosaminoglycans, which can cause various health issues, including skeletal abnormalities, joint problems, and respiratory difficulties. Individuals with MPS IV often experience symptoms such as short stature, a curved spine, and issues with mobility. Early diagnosis and treatment, including enzyme replacement therapy, can help manage symptoms and improve quality of life for those affected by this condition.